Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Viral Hepatitis National Strategic Plan for the United States, released by HHS, offers a road map for the next five years.
The link between COVID-19 and liver disease, along with research about NAFLD and NASH, topped the Hep treatment news this year.
Two different studies found that Vemlidy was safe and effective for pregnant women and their infants.
Areas with lower population density have not seen the same slowdown as urban areas.
The Centers for Disease Control and Prevention has learned difficult lessons from such outbreaks over the past five years.
Culturally mindful educational programs may help Black people seek help earlier and throttle hep B incidence rates in these communities.
What is the difference between a liver biopsy and a Fibroscan?
A recent study also found that having a higher body mass index was associated with a higher risk of fatty liver disease.
Comment on the draft Viral Hepatitis National Strategic Plan; details in the Federal Register.
People with advanced liver cirrhosis are at greater risk for severe COVID-19 illness and death.
NAIRHHA Day also brings focus to other epidemics fueling HIV disparities.
People who switched showed improvement in markers of kidney and bone health but also rise in lipid levels.
Liver complications, heart disease and non-liver cancers also account for most deaths among people with hepatitis B or C.
A high success rate was seen halfway into a 48-week study in which people with HIV started treatment within two weeks of diagnosis.
Coinfection with all three viruses ramped up mortality risk nine times compared with having none of the viruses.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.